Jiayan Liu

1.2k total citations
29 papers, 920 citations indexed

About

Jiayan Liu is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jiayan Liu has authored 29 papers receiving a total of 920 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 12 papers in Endocrinology, Diabetes and Metabolism and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jiayan Liu's work include Hormonal and reproductive studies (8 papers), Sexual Differentiation and Disorders (6 papers) and Prostate Cancer Treatment and Research (6 papers). Jiayan Liu is often cited by papers focused on Hormonal and reproductive studies (8 papers), Sexual Differentiation and Disorders (6 papers) and Prostate Cancer Treatment and Research (6 papers). Jiayan Liu collaborates with scholars based in United States, China and Germany. Jiayan Liu's co-authors include Richard J. Auchus, Nima Sharifi, Rui Li, Kai‐Hsiung Chang, Jorge A. García, Zhenfei Li, Dustin R. Bunch, Mohammad Alyamani, Robert Dreicer and Andrew C. Bishop and has published in prestigious journals such as Nature, Cell and Journal of Biological Chemistry.

In The Last Decade

Jiayan Liu

29 papers receiving 912 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiayan Liu United States 14 478 381 363 193 186 29 920
Zixin Zhu China 13 144 0.3× 162 0.4× 306 0.8× 95 0.5× 138 0.7× 22 668
Jaime Jacqueline Jayapalan Malaysia 16 68 0.1× 184 0.5× 373 1.0× 48 0.2× 98 0.5× 42 800
Peter Ofner United States 19 360 0.8× 612 1.6× 293 0.8× 271 1.4× 72 0.4× 44 1.1k
Debra L. Bemis United States 13 180 0.4× 41 0.1× 557 1.5× 69 0.4× 165 0.9× 21 1.0k
Maureen O. Ripple United States 16 119 0.2× 57 0.1× 552 1.5× 99 0.5× 132 0.7× 21 895
Ramadevi Subramani United States 21 75 0.2× 117 0.3× 631 1.7× 95 0.5× 372 2.0× 32 1.0k
Rong Fu China 18 187 0.4× 39 0.1× 499 1.4× 108 0.6× 262 1.4× 41 947
Holly D. Cox United States 18 73 0.2× 241 0.6× 301 0.8× 51 0.3× 66 0.4× 37 840
Luís Gaspar Portugal 11 280 0.6× 38 0.1× 117 0.3× 38 0.2× 42 0.2× 18 857
Noriko Kanaya United States 17 107 0.2× 32 0.1× 335 0.9× 119 0.6× 113 0.6× 27 715

Countries citing papers authored by Jiayan Liu

Since Specialization
Citations

This map shows the geographic impact of Jiayan Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiayan Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiayan Liu more than expected).

Fields of papers citing papers by Jiayan Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiayan Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiayan Liu. The network helps show where Jiayan Liu may publish in the future.

Co-authorship network of co-authors of Jiayan Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Jiayan Liu. A scholar is included among the top collaborators of Jiayan Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiayan Liu. Jiayan Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Jiayan, Liming Jin, Tao Mi, et al.. (2024). ZSTK474 targeting PIK3R3 inhibits the Wilms’ tumor through G0 / G1 phase arrest. PLoS ONE. 19(10). e0312178–e0312178. 1 indexed citations
2.
Liu, Jiayan, et al.. (2024). Transdermal Drug Delivery System of Linagliptin Sustained-release Microparticle Gels: In vitro Characterization and In vivo Evaluation. Current Drug Delivery. 21(11). 1537–1547. 2 indexed citations
3.
Wang, Zhang, Liming Jin, Jinkui Wang, et al.. (2024). Recruitment and polarization typing of tumor-associated macrophages is associated with tumor progression and poor prognosis in Wilms tumor patients. PLoS ONE. 19(11). e0309910–e0309910. 1 indexed citations
4.
Liu, Jiayan, Tao Mi, Zhaoxia Zhang, et al.. (2023). BKM120 inhibits malignant rhabdoid tumor of the kidney through induction of apoptosis and G0/G1 phase arrest. European Journal of Pharmacology. 951. 175747–175747. 4 indexed citations
5.
Liu, Jiayan, et al.. (2023). The impact of obesity on lung function measurements and respiratory disease: A Mendelian randomization study. Annals of Human Genetics. 87(4). 174–183. 5 indexed citations
6.
Liu, Jiayan, Yuxin Fu, Shuaishuai Zhou, et al.. (2023). Comparison of the effect of quercetin and daidzein on production performance, anti-oxidation, hormones, and cecal microflora in laying hens during the late laying period. Poultry Science. 102(6). 102674–102674. 23 indexed citations
7.
Zhanghuang, Chenghao, Zhaoxia Zhang, Tao Mi, et al.. (2022). Doxycycline Hydrochloride Regulates Cytoskeletal Rearrangement and Epithelial‐To‐Mesenchymal Transition in Malignant Rhabdoid Tumour of the Kidney. BioMed Research International. 2022(1). 2760744–2760744. 2 indexed citations
8.
9.
Li, Mujie, Jinkui Wang, Peng Guo, et al.. (2022). Exosome mimetics derived from bone marrow mesenchymal stem cells ablate neuroblastoma tumor in vitro and in vivo. Biomaterials Advances. 142. 213161–213161. 6 indexed citations
10.
Wang, Mi, Bo Wang, Shuaishuai Zhou, et al.. (2022). Quercetin ameliorates chicken quality by activating the PI3K/PKB/AMPK signaling pathway in broilers. Frontiers in Veterinary Science. 9. 951512–951512. 11 indexed citations
11.
12.
Liao, Yuxiao, Zhao Peng, Liangliang Wang, et al.. (2020). Long noncoding RNA Gm20319, acting as competing endogenous RNA, regulated GNE expression by sponging miR-7240-5p to involve in deoxynivalenol-induced liver damage in vitro. Food and Chemical Toxicology. 141. 111435–111435. 16 indexed citations
13.
Miao, Hui, Zhongxun Yu, Lin Lü, et al.. (2019). Analysis of novel heterozygous mutations in the CYP11B2 gene causing congenital aldosterone synthase deficiency and literature review. Steroids. 150. 108448–108448. 11 indexed citations
14.
Liu, Teresa T., Melanie Grubisha, Stacy G. Wendell, et al.. (2016). Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-Reductase Inhibition in Prostate Epithelial Cells. Journal of Biological Chemistry. 291(28). 14747–14760. 8 indexed citations
15.
Ritz, Thomas, Ana F. Trueba, Jiayan Liu, Richard J. Auchus, & David Rosenfield. (2015). Exhaled Nitric Oxide Decreases during Academic Examination Stress in Asthma. Annals of the American Thoracic Society. 12(11). 1638–1645. 24 indexed citations
16.
Li, Zhenfei, Andrew C. Bishop, Mohammad Alyamani, et al.. (2015). Conversion of abiraterone to D4A drives anti-tumour activity in prostate cancer. Nature. 523(7560). 347–351. 205 indexed citations
17.
Mizrachi, Dario, Yujie Chen, Jiayan Liu, et al.. (2015). Making water-soluble integral membrane proteins in vivo using an amphipathic protein fusion strategy. Nature Communications. 6(1). 6826–6826. 25 indexed citations
18.
Peng, Hwei‐Ming, et al.. (2014). Catalytically Relevant Electrostatic Interactions of Cytochrome P450c17 (CYP17A1) and Cytochrome b5. Journal of Biological Chemistry. 289(49). 33838–33849. 34 indexed citations
19.
Chang, Kai‐Hsiung, Rui Li, Barbara Kuri, et al.. (2013). A Gain-of-Function Mutation in DHT Synthesis in Castration-Resistant Prostate Cancer. Cell. 154(5). 1074–1084. 242 indexed citations
20.
Li, Rui, Kamalesh Kumar Sharma, Kai‐Hsiung Chang, et al.. (2012). Abiraterone Inhibits 3β-Hydroxysteroid Dehydrogenase: A Rationale for Increasing Drug Exposure in Castration-Resistant Prostate Cancer. Clinical Cancer Research. 18(13). 3571–3579. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zixin Zhu Breakdown of academic impact, for papers by Jaime Jacqueline Jayapalan Breakdown of academic impact, for papers by Peter Ofner Breakdown of academic impact, for papers by Debra L. Bemis Breakdown of academic impact, for papers by Maureen O. Ripple Breakdown of academic impact, for papers by Ramadevi Subramani Breakdown of academic impact, for papers by Rong Fu Breakdown of academic impact, for papers by Holly D. Cox Breakdown of academic impact, for papers by Luís Gaspar Breakdown of academic impact, for papers by Noriko Kanaya
Rankless by CCL
2026